| 000 | 01575 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518000025.0 | ||
| 264 | 0 | _c20190314 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1539-1612 | ||
| 024 | 7 |
_a10.1002/pst.1905 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTurkoz, Ibrahim | |
| 245 | 0 | 0 |
_aApplication of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modification. _h[electronic resource] |
| 260 |
_bPharmaceutical statistics _c01 2019 |
||
| 300 |
_a22-38 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aBiostatistics _xmethods |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEndpoint Determination _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aPaliperidone Palmitate _xadministration & dosage |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aResearch Design _xstatistics & numerical data |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSobel, Marc | |
| 700 | 1 | _aAlphs, Larry | |
| 773 | 0 |
_tPharmaceutical statistics _gvol. 18 _gno. 1 _gp. 22-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pst.1905 _zAvailable from publisher's website |
| 999 |
_c28841537 _d28841537 |
||